MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C

K. Thabet, A. Asimakopoulos, M. Shojaei, M. Romero-Gomez, A. Mangia, W.L. Irving, T. Berg, G.J. Dore, H. Grønbæk, D. Sheridan, M.L. Abate, E. Bugianesi, M. Weltman, Lindsay Mollison, W. Cheng, S. Riordan, J. Fischer, U. Spengler, J. Nattermann, A. WahidA. Rojas, R. White, M.W. Douglas, D. Mcleod, E. Powell, C. Liddle, D. Van Der Poorten, J. George, M. Eslam, R. Gallego-Duran, T. Applegate, M. Bassendine, C. Rosso, L. Mezzabotta, R. Leung, B. Malik, G. Matthews, J. Grebely, V. Fragomeli, J.R. Jonsson, R. Santaro

Research output: Contribution to journalArticlepeer-review

93 Citations (Scopus)


© 2016 The Author(s).
Cirrhosis likely shares common pathophysiological pathways despite arising from a variety of liver diseases. A recent GWAS identified rs641738, a polymorphism in the MBOAT7 locus, as being associated with the development of alcoholic cirrhosis. Here we explore the role of this variant on liver inflammation and fibrosis in two cohorts of patients with chronic hepatitis C. In 2,051 patients, rs641738 associated with severe hepatic inflammation and increased risk of fibrosis, as well as fast fibrosis progression. At functional level, rs641738 associated with MBOAT7 transcript and protein levels in liver and blood, and with serum inflammatory, oxidative stress and macrophage activation markers. MBOAT7 was expressed in immune cell subsets, implying a role in hepatic inflammation. We conclude that the MBOAT7 rs641738 polymorphism is a novel risk variant for liver inflammation in hepatitis C, and thereby for liver fibrosis.
Original languageEnglish
Article number12757
Pages (from-to)1-8
JournalNature Communications
Publication statusPublished - 15 Sept 2016
Externally publishedYes


Dive into the research topics of 'MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C'. Together they form a unique fingerprint.

Cite this